UAB 18107 - A Phase 2, Single Arm Study of Atezolizumab + Bevacizumab in Women with Advanced, Recurrent or Persistent Endometrial Cancer

Grant

Awarded By

Total Award Amount

  • 202458.00
  • Direct Costs

  • 155737.00
  • Sponsor Award Id

  • Contributor

  • Charles Leath M.D.   Investigator  
  • Margaret Liang   Investigator  
  • Rebecca Arend M.D.   Principal Investigator  
  • Warner Huh M.D.   Investigator